Report Detail
Global Quetiapine Fumarate Market Research Report 2019
- RnM2881936 |
- 05 February, 2019 |
- Global |
- 102 Pages |
- QYResearch |
- Pharma & Healthcare
Quetiapine Fumarate is an atypical antipsychotic drug used to treat psychiatric disorders such as schizophrenia, bipolar disorder and depression. It may be used alone or in combination with other psychiatric medications. It is taken orally, and is available only by prescription, under the supervision of a medical practitioner.
The Quetiapine Fumarate was developed by AstraZeneca from 1992 to 1996. It was first approved by the FDA in 1997.
The product is invented and first produced in the UK by AstraZeneca. AstraZeneca is also the leader of the Quetiapine Fumarate base drugs.
The Average gross of the industry is over 40%. However, since there are new companies coming into the area, the gross is declining in the last several years.
The global Quetiapine Fumarate market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Quetiapine Fumarate volume and value at global level, regional level and company level. From a global perspective, this report represents overall Quetiapine Fumarate market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
AstraZeneca
Intas
TAPI
Accord
Hexal
Dr.Reddy's
Lupin
Sun Pharmaceutical
Hunan Dongting Pharm
SuZhou NO.4 Phamaceutical Factory
Fuan Pharmaceutical
Zhejiang Supor Pharmaceuticals
Zhejiang Huahai Pharmaceutical
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Immediate Release Tablets
Extended Release Tablets
Segment by Application
Application I
Application II
Table of Contents
Executive Summary
1 Quetiapine Fumarate Market Overview
- 1.1 Product Overview and Scope of Quetiapine Fumarate
- 1.2 Quetiapine Fumarate Segment by Type
- 1.2.1 Global Quetiapine Fumarate Production Growth Rate Comparison by Type (2014-2025)
- 1.2.2 Immediate Release Tablets
- 1.2.3 Extended Release Tablets
- 1.3 Quetiapine Fumarate Segment by Application
- 1.3.1 Quetiapine Fumarate Consumption Comparison by Application (2014-2025)
- 1.3.2 Application I
- 1.3.3 Application II
- 1.3 Global Quetiapine Fumarate Market by Region
- 1.3.1 Global Quetiapine Fumarate Market Size Region
- 1.3.2 North America Status and Prospect (2014-2025)
- 1.3.3 Europe Status and Prospect (2014-2025)
- 1.3.4 China Status and Prospect (2014-2025)
- 1.3.5 Japan Status and Prospect (2014-2025)
- 1.3.6 Southeast Asia Status and Prospect (2014-2025)
- 1.3.7 India Status and Prospect (2014-2025)
- 1.4 Global Quetiapine Fumarate Market Size
- 1.4.1 Global Quetiapine Fumarate Revenue (2014-2025)
- 1.4.2 Global Quetiapine Fumarate Production (2014-2025)
2 Global Quetiapine Fumarate Market Competition by Manufacturers
- 2.1 Global Quetiapine Fumarate Production Market Share by Manufacturers (2014-2019)
- 2.2 Global Quetiapine Fumarate Revenue Share by Manufacturers (2014-2019)
- 2.3 Global Quetiapine Fumarate Average Price by Manufacturers (2014-2019)
- 2.4 Manufacturers Quetiapine Fumarate Production Sites, Area Served, Product Types
- 2.5 Quetiapine Fumarate Market Competitive Situation and Trends
- 2.5.1 Quetiapine Fumarate Market Concentration Rate
- 2.5.2 Quetiapine Fumarate Market Share of Top 3 and Top 5 Manufacturers
- 2.5.3 Mergers & Acquisitions, Expansion
3 Global Quetiapine Fumarate Production Market Share by Regions
- 3.1 Global Quetiapine Fumarate Production Market Share by Regions
- 3.2 Global Quetiapine Fumarate Revenue Market Share by Regions (2014-2019)
- 3.3 Global Quetiapine Fumarate Production, Revenue, Price and Gross Margin (2014-2019)
- 3.4 North America Quetiapine Fumarate Production
- 3.4.1 North America Quetiapine Fumarate Production Growth Rate (2014-2019)
- 3.4.2 North America Quetiapine Fumarate Production, Revenue, Price and Gross Margin (2014-2019)
- 3.5 Europe Quetiapine Fumarate Production
- 3.5.1 Europe Quetiapine Fumarate Production Growth Rate (2014-2019)
- 3.5.2 Europe Quetiapine Fumarate Production, Revenue, Price and Gross Margin (2014-2019)
- 3.6 China Quetiapine Fumarate Production (2014-2019)
- 3.6.1 China Quetiapine Fumarate Production Growth Rate (2014-2019)
- 3.6.2 China Quetiapine Fumarate Production, Revenue, Price and Gross Margin (2014-2019)
- 3.7 Japan Quetiapine Fumarate Production (2014-2019)
- 3.7.1 Japan Quetiapine Fumarate Production Growth Rate (2014-2019)
- 3.7.2 Japan Quetiapine Fumarate Production, Revenue, Price and Gross Margin (2014-2019)
4 Global Quetiapine Fumarate Consumption by Regions
- 4.1 Global Quetiapine Fumarate Consumption by Regions
- 4.2 North America Quetiapine Fumarate Consumption (2014-2019)
- 4.3 Europe Quetiapine Fumarate Consumption (2014-2019)
- 4.4 China Quetiapine Fumarate Consumption (2014-2019)
- 4.5 Japan Quetiapine Fumarate Consumption (2014-2019)
5 Global Quetiapine Fumarate Production, Revenue, Price Trend by Type
- 5.1 Global Quetiapine Fumarate Production Market Share by Type (2014-2019)
- 5.2 Global Quetiapine Fumarate Revenue Market Share by Type (2014-2019)
- 5.3 Global Quetiapine Fumarate Price by Type (2014-2019)
- 5.4 Global Quetiapine Fumarate Production Growth by Type (2014-2019)
6 Global Quetiapine Fumarate Market Analysis by Applications
- 6.1 Global Quetiapine Fumarate Consumption Market Share by Application (2014-2019)
- 6.2 Global Quetiapine Fumarate Consumption Growth Rate by Application (2014-2019)
7 Company Profiles and Key Figures in Quetiapine Fumarate Business
- 7.1 AstraZeneca
- 7.1.1 AstraZeneca Quetiapine Fumarate Production Sites and Area Served
- 7.1.2 Quetiapine Fumarate Product Introduction, Application and Specification
- 7.1.3 AstraZeneca Quetiapine Fumarate Production, Revenue, Price and Gross Margin (2014-2019)
- 7.1.4 Main Business and Markets Served
- 7.2 Intas
- 7.2.1 Intas Quetiapine Fumarate Production Sites and Area Served
- 7.2.2 Quetiapine Fumarate Product Introduction, Application and Specification
- 7.2.3 Intas Quetiapine Fumarate Production, Revenue, Price and Gross Margin (2014-2019)
- 7.2.4 Main Business and Markets Served
- 7.3 TAPI
- 7.3.1 TAPI Quetiapine Fumarate Production Sites and Area Served
- 7.3.2 Quetiapine Fumarate Product Introduction, Application and Specification
- 7.3.3 TAPI Quetiapine Fumarate Production, Revenue, Price and Gross Margin (2014-2019)
- 7.3.4 Main Business and Markets Served
- 7.4 Accord
- 7.4.1 Accord Quetiapine Fumarate Production Sites and Area Served
- 7.4.2 Quetiapine Fumarate Product Introduction, Application and Specification
- 7.4.3 Accord Quetiapine Fumarate Production, Revenue, Price and Gross Margin (2014-2019)
- 7.4.4 Main Business and Markets Served
- 7.5 Hexal
- 7.5.1 Hexal Quetiapine Fumarate Production Sites and Area Served
- 7.5.2 Quetiapine Fumarate Product Introduction, Application and Specification
- 7.5.3 Hexal Quetiapine Fumarate Production, Revenue, Price and Gross Margin (2014-2019)
- 7.5.4 Main Business and Markets Served
- 7.6 Dr.Reddy's
- 7.6.1 Dr.Reddy's Quetiapine Fumarate Production Sites and Area Served
- 7.6.2 Quetiapine Fumarate Product Introduction, Application and Specification
- 7.6.3 Dr.Reddy's Quetiapine Fumarate Production, Revenue, Price and Gross Margin (2014-2019)
- 7.6.4 Main Business and Markets Served
- 7.7 Lupin
- 7.7.1 Lupin Quetiapine Fumarate Production Sites and Area Served
- 7.7.2 Quetiapine Fumarate Product Introduction, Application and Specification
- 7.7.3 Lupin Quetiapine Fumarate Production, Revenue, Price and Gross Margin (2014-2019)
- 7.7.4 Main Business and Markets Served
- 7.8 Sun Pharmaceutical
- 7.8.1 Sun Pharmaceutical Quetiapine Fumarate Production Sites and Area Served
- 7.8.2 Quetiapine Fumarate Product Introduction, Application and Specification
- 7.8.3 Sun Pharmaceutical Quetiapine Fumarate Production, Revenue, Price and Gross Margin (2014-2019)
- 7.8.4 Main Business and Markets Served
- 7.9 Hunan Dongting Pharm
- 7.9.1 Hunan Dongting Pharm Quetiapine Fumarate Production Sites and Area Served
- 7.9.2 Quetiapine Fumarate Product Introduction, Application and Specification
- 7.9.3 Hunan Dongting Pharm Quetiapine Fumarate Production, Revenue, Price and Gross Margin (2014-2019)
- 7.9.4 Main Business and Markets Served
- 7.10 SuZhou NO.4 Phamaceutical Factory
- 7.10.1 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Production Sites and Area Served
- 7.10.2 Quetiapine Fumarate Product Introduction, Application and Specification
- 7.10.3 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Production, Revenue, Price and Gross Margin (2014-2019)
- 7.10.4 Main Business and Markets Served
- 7.11 Fuan Pharmaceutical
- 7.12 Zhejiang Supor Pharmaceuticals
- 7.13 Zhejiang Huahai Pharmaceutical
8 Quetiapine Fumarate Manufacturing Cost Analysis
- 8.1 Quetiapine Fumarate Key Raw Materials Analysis
- 8.1.1 Key Raw Materials
- 8.1.2 Price Trend of Key Raw Materials
- 8.1.3 Key Suppliers of Raw Materials
- 8.2 Proportion of Manufacturing Cost Structure
- 8.3 Manufacturing Process Analysis of Quetiapine Fumarate
- 8.4 Quetiapine Fumarate Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
- 9.1 Marketing Channel
- 9.1.1 Direct Marketing
- 9.1.2 Indirect Marketing
- 9.2 Quetiapine Fumarate Distributors List
- 9.3 Quetiapine Fumarate Customers
10 Market Dynamics
- 10.1 Market Trends
- 10.2 Opportunities
- 10.3 Market Drivers
- 10.4 Challenges
- 10.5 Influence Factors
11 Global Quetiapine Fumarate Market Forecast
- 11.1 Global Quetiapine Fumarate Production, Revenue Forecast
- 11.1.1 Global Quetiapine Fumarate Production Growth Rate Forecast (2019-2025)
- 11.1.2 Global Quetiapine Fumarate Revenue and Growth Rate Forecast (2019-2025)
- 11.1.3 Global Quetiapine Fumarate Price and Trend Forecast (2019-2025)
- 11.2 Global Quetiapine Fumarate Production Forecast by Regions (2019-2025)
- 11.2.1 North America Quetiapine Fumarate Production, Revenue Forecast (2019-2025)
- 11.2.2 Europe Quetiapine Fumarate Production, Revenue Forecast (2019-2025)
- 11.2.3 China Quetiapine Fumarate Production, Revenue Forecast (2019-2025)
- 11.2.4 Japan Quetiapine Fumarate Production, Revenue Forecast (2019-2025)
- 11.3 Global Quetiapine Fumarate Consumption Forecast by Regions (2019-2025)
- 11.3.1 North America Quetiapine Fumarate Consumption Forecast (2019-2025)
- 11.3.2 Europe Quetiapine Fumarate Consumption Forecast (2019-2025)
- 11.3.3 China Quetiapine Fumarate Consumption Forecast (2019-2025)
- 11.3.4 Japan Quetiapine Fumarate Consumption Forecast (2019-2025)
- 11.4 Global Quetiapine Fumarate Production, Revenue and Price Forecast by Type (2019-2025)
- 11.5 Global Quetiapine Fumarate Consumption Forecast by Application (2019-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Quetiapine Fumarate . Industry analysis & Market Report on Quetiapine Fumarate is a syndicated market report, published as Global Quetiapine Fumarate Market Research Report 2019. It is complete Research Study and Industry Analysis of Quetiapine Fumarate market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
